Clinical Trials Directory

Trials / Completed

CompletedNCT02498431

Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention

Serum Irisin Levels in Myocardial Infraction and Following Percutaneous Coronary Intevention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
116 (actual)
Sponsor
424 General Military Hospital · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to evaluate circulating irisin levels alterations in patients with acute myocardial infraction and in patients with coronary artery disease subjected to percutaneous coronary intervention.

Detailed description

Irisin is a newly discovered myokine induced in exercise. There is evidence that cardiac muscle produces more irisin than skeletal muscle in response to exercise. Furthermore, irisin has been associated with isoproterenol-induced myocardial infarction (MI) in rats while it has been reported to decrease after acute myocardial infarction in humans. The investigators aim 1) to investigate circulating irisin levels in patients at the time of acute myocardial infarction and after reprefusion \[primary percutaneous coronary intervention (PCI)\] 2) to compare irisin' s diagnostic and prognostic value and specificity value in myocardial infarction with known markers of cardiac injury such as creatine kinase-MB isoenzyme (CK-MB) and troponin 3) to evaluate irisin as an early necrosis biomarker 4) To evaluate irisin's sensitivity as a biomarker to detect minor myocardial necrosis after elective percutaneous coronary intervention

Conditions

Interventions

TypeNameDescription
PROCEDUREpercutaneous coronary interventiona non-surgical procedure used to treat the stenotic (narrowed) coronary arteries of the heart found in coronary heart disease
PROCEDUREcoronary angiographyis a procedure performed along with cardiac catheterization that uses X-ray imaging to see your heart's blood vessels
DEVICEStent, Medronic Resolute IntegrityA stent is placed in an artery as part of a procedure called percutaneous coronary intervention (PCI) to restore blood flow through narrow or blocked arteries. A stent helps support the inner wall of the artery in the months or years after PCI.

Timeline

Start date
2015-06-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-07-15
Last updated
2017-01-18

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT02498431. Inclusion in this directory is not an endorsement.